Advertisement

Search Results for "Cholorquine Vs Coartem"

08:08 EDT 22nd May 2013 | BioPortfolio

Original Source: Chloroquine and Coartem for Treatment of Symptomatic Children With Plasmodium Falciparum in Guinea Bissau

This study will evaluate the efficacy of treatment with artemether-lumefantrine as compared to chloroquine in the dose of 50 mg/kg for treatment of malaria in children in Guinea-Bissau. The genetic basis of the parasites for developing resistance will be examined. Children coming to one of the Health Centres with symptoms of malaria and a positive malaria test will be included. The children will be followed weekly until day 70. In case of reappearance of parasites the child wil...

Matching Channels

None

Matching News

Novartis Typhoid Vaccine Seeks Partner After Securing Pakistan Clinical Trial Site

Phase II study is ongoing in Pakistan, a year after Novartis convinced the Pakistani government to lift its ban on clinical trials. Antimalarials with a different mechanism of action than Coartem are...

FDA lowers fee to use Priority Review voucher

FDA set the fee for companies to use a Priority Review voucher at $3.6 million for FY13, down from $5.3 million in FY12. The fee is adjusted each fiscal year to account for the difference between the...

The Galien Foundation Announces New "Best Medical Technology" Award Category for 2012 Prix Galien USA Awards Program

NEW YORK, May 30, 2012 /PRNewswire/ -- The Galien Foundation announced today a new award category for the Prix Galien USA Awards, honoring innovation in biopharmaceuticals and medical technologies: "B...

Galien Foundation selects NovoTTF™-100A System as a finalist for the Prix Galien USA Award

NEW YORK, Aug. 9, 2012 /PRNewswire/ -- The Galien Foundation announced today that it has selected the NovoTTF™-100A System as a finalist for the prestigious Prix Galien USA Award in Best Medical...

Galien Foundation Announces Final Program for 3rd Annual Galien Forum on October 16

NEW YORK, Oct. 12, 2012 /PRNewswire/ -- The Galien Foundation Board announced today the final program for the 3rd Annual Galien Forum to be held in New York City at the Alexandria Center™ for Li...

Prix Galien USA Salutes Excellence in Scientific Innovation and Humanitarian Efforts at 2012 Awards Gala

NEW YORK, Oct. 17, 2012 /PRNewswire/ -- As part of its ongoing mission to recognize the technical, scientific and clinical research skills necessary to develop innovative medicines, the Prix Gali...

The Galien Foundation Announces Roster of Luminary Presenters for Third Galien Forum; Program Highlights Include CEO Panel, Panel on Alzheimer's Disease Innovation, Nobel Laureate Elie Wiesel

NEW YORK, July 9, 2012 /PRNewswire/ -- The Galien Foundation today announced the formal program of presenters and panels for its Third Galien Forum, scheduled for Tuesday, October 16, 2012 at the...

Novartis signs on to support Malaria No More's Power of One campaign to stride towards a future without malaria

Novartis International AG / Novartis signs on to support Malaria No More's Power of One campaign to stride towards a future without malaria . Processed and transmitted by Thomson Reuters ONE. T...

Matching PubMed Articles

Treatment of fevers prior to introducing rapid diagnostic tests for malaria in registered drug shops in Uganda.

BACKGROUND: Since drug shops play an important role in treatment of fever, introducing rapid diagnostic tests (RDTs) for malaria at drug shops may have the potential of targeting anti-malarial drugs t...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement